These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

500 related articles for article (PubMed ID: 29931613)

  • 1. The Gut Microbiome as a Target for the Treatment of Type 2 Diabetes.
    Aydin Ö; Nieuwdorp M; Gerdes V
    Curr Diab Rep; 2018 Jun; 18(8):55. PubMed ID: 29931613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolites Linking the Gut Microbiome with Risk for Type 2 Diabetes.
    Zhu T; Goodarzi MO
    Curr Nutr Rep; 2020 Jun; 9(2):83-93. PubMed ID: 32157661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut Microbiota as a Trigger for Metabolic Inflammation in Obesity and Type 2 Diabetes.
    Scheithauer TPM; Rampanelli E; Nieuwdorp M; Vallance BA; Verchere CB; van Raalte DH; Herrema H
    Front Immunol; 2020; 11():571731. PubMed ID: 33178196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the gut microbiota in type 2 diabetes and related diseases.
    Yang G; Wei J; Liu P; Zhang Q; Tian Y; Hou G; Meng L; Xin Y; Jiang X
    Metabolism; 2021 Apr; 117():154712. PubMed ID: 33497712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered Gut Microbiota in Type 2 Diabetes: Just a Coincidence?
    Sircana A; Framarin L; Leone N; Berrutti M; Castellino F; Parente R; De Michieli F; Paschetta E; Musso G
    Curr Diab Rep; 2018 Sep; 18(10):98. PubMed ID: 30215149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding the Role of the Gut Microbiome and Microbial Metabolites in Obesity and Obesity-Associated Metabolic Disorders: Current Evidence and Perspectives.
    Vallianou N; Stratigou T; Christodoulatos GS; Dalamaga M
    Curr Obes Rep; 2019 Sep; 8(3):317-332. PubMed ID: 31175629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut microbiome and type 2 diabetes: where we are and where to go?
    Sharma S; Tripathi P
    J Nutr Biochem; 2019 Jan; 63():101-108. PubMed ID: 30366260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut microbiota and type 2 diabetes mellitus.
    Muñoz-Garach A; Diaz-Perdigones C; Tinahones FJ
    Endocrinol Nutr; 2016 Dec; 63(10):560-568. PubMed ID: 27633134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut-Microbial Metabolites, Probiotics and Their Roles in Type 2 Diabetes.
    Zhai L; Wu J; Lam YY; Kwan HY; Bian ZX; Wong HLX
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of Gut Microbiota in the development of obesity and Diabetes.
    Baothman OA; Zamzami MA; Taher I; Abubaker J; Abu-Farha M
    Lipids Health Dis; 2016 Jun; 15():108. PubMed ID: 27317359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.
    Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
    Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the Gut Microbiota: Key Insights Into Its Role in Obesity, Metabolic Syndrome, and Type 2 Diabetes.
    Sasidharan Pillai S; Gagnon CA; Foster C; Ashraf AP
    J Clin Endocrinol Metab; 2024 Oct; 109(11):2709-2719. PubMed ID: 39040013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders.
    Aron-Wisnewsky J; Vigliotti C; Witjes J; Le P; Holleboom AG; Verheij J; Nieuwdorp M; Clément K
    Nat Rev Gastroenterol Hepatol; 2020 May; 17(5):279-297. PubMed ID: 32152478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Microbiota and obesity].
    Karney A
    Dev Period Med; 2017; 21(3):203-207. PubMed ID: 29077559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beneficial effects of exercise on gut microbiota functionality and barrier integrity, and gut-liver crosstalk in an
    Carbajo-Pescador S; Porras D; García-Mediavilla MV; Martínez-Flórez S; Juarez-Fernández M; Cuevas MJ; Mauriz JL; González-Gallego J; Nistal E; Sánchez-Campos S
    Dis Model Mech; 2019 Apr; 12(5):. PubMed ID: 30971408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reconstruction of intestinal microecology of type 2 diabetes by fecal microbiota transplantation: Why and how.
    Hou K; Zhang S; Wu Z; Zhu D; Chen F; Lei ZN; Liu W; Xiao C; Chen ZS
    Bosn J Basic Med Sci; 2022 Jun; 22(3):315-325. PubMed ID: 34761734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism and Metabolic Disorders and the Microbiome: The Intestinal Microbiota Associated With Obesity, Lipid Metabolism, and Metabolic Health-Pathophysiology and Therapeutic Strategies.
    Aron-Wisnewsky J; Warmbrunn MV; Nieuwdorp M; Clément K
    Gastroenterology; 2021 Jan; 160(2):573-599. PubMed ID: 33253685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the Gut Microbiome in the Pathogenesis of Obesity and Obesity-Related Metabolic Dysfunction.
    Bouter KE; van Raalte DH; Groen AK; Nieuwdorp M
    Gastroenterology; 2017 May; 152(7):1671-1678. PubMed ID: 28192102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-scale community modelling elucidates the metabolic interaction in Indian type-2 diabetic gut microbiota.
    Beura S; Kundu P; Das AK; Ghosh A
    Sci Rep; 2024 Jul; 14(1):17259. PubMed ID: 39060274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut Microbiota and Complications of Type-2 Diabetes.
    Iatcu CO; Steen A; Covasa M
    Nutrients; 2021 Dec; 14(1):. PubMed ID: 35011044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.